272
Participants
Start Date
July 29, 2008
Primary Completion Date
January 31, 2012
Study Completion Date
January 31, 2012
otelixizumab infusion plus physician determined standard of care
infusion
placebo infusion plus physician determined standard of care
infusion
GSK Investigational Site, Arhus C
GSK Investigational Site, Barcelona
GSK Investigational Site, New York
GSK Investigational Site, Mineola
GSK Investigational Site, Berlin
GSK Investigational Site, Buffalo
GSK Investigational Site, Rochester
GSK Investigational Site, Langhorne
GSK Investigational Site, Philadelphia
GSK Investigational Site, Washington D.C.
GSK Investigational Site, Milan
GSK Investigational Site, Turku
GSK Investigational Site, Baltimore
GSK Investigational Site, Atlanta
GSK Investigational Site, Durham
GSK Investigational Site, Madrid
GSK Investigational Site, Atlanta
GSK Investigational Site, Atlanta
GSK Investigational Site, Winter Park
GSK Investigational Site, Orlando
GSK Investigational Site, Orlando
GSK Investigational Site, Pembroke Pines
GSK Investigational Site, Miami
GSK Investigational Site, Miami
GSK Investigational Site, Jupiter
GSK Investigational Site, Boca Raton
GSK Investigational Site, Tampere
GSK Investigational Site, Trinity
GSK Investigational Site, Birmingham
GSK Investigational Site, Nashville
GSK Investigational Site, Chattanooga
GSK Investigational Site, Bad Lauterberg im Harz
GSK Investigational Site, Memphis
GSK Investigational Site, Gulfport
GSK Investigational Site, Columbus
GSK Investigational Site, Columbus
GSK Investigational Site, Mentor
GSK Investigational Site, Indianapolis
GSK Investigational Site, Detroit
GSK Investigational Site, Kalamazoo
GSK Investigational Site, Rapid City
GSK Investigational Site, Chicago
GSK Investigational Site, Chicago
GSK Investigational Site, Bad Nauheim
GSK Investigational Site, St Louis
GSK Investigational Site, Kansas City
GSK Investigational Site, Columbia
GSK Investigational Site, Topeka
GSK Investigational Site, Omaha
GSK Investigational Site, Heidelberg
GSK Investigational Site, Little Rock
GSK Investigational Site, Dallas
GSK Investigational Site, Dallas
GSK Investigational Site, Hurst
GSK Investigational Site, Houston
GSK Investigational Site, San Antonio
GSK Investigational Site, Aurora
GSK Investigational Site, Boise
GSK Investigational Site, Ogden
GSK Investigational Site, Los Angeles
GSK Investigational Site, Palermo
GSK Investigational Site, Torrance
GSK Investigational Site, Riverside
GSK Investigational Site, Costa Mesa
GSK Investigational Site, Santa Ana
GSK Investigational Site, Orange
GSK Investigational Site, Walnut Creek
GSK Investigational Site, Honolulu
GSK Investigational Site, Portland
GSK Investigational Site, Eugene
GSK Investigational Site, Tacoma
GSK Investigational Site, Schertz
GSK Investigational Site, Idaho Falls
GSK Investigational Site, Worcester
GSK Investigational Site, Neptune City
GSK Investigational Site, Dayton
GSK Investigational Site, Tulsa
GSK Investigational Site, Charleston
GSK Investigational Site, Calgary
GSK Investigational Site, Oakville
GSK Investigational Site, Smiths Falls
GSK Investigational Site, Toronto
GSK Investigational Site, Montreal
GSK Investigational Site, Pointe-Claire
GSK Investigational Site, Latina
GSK Investigational Site, Rome
GSK Investigational Site, Rome
GSK Investigational Site, Rome
GSK Investigational Site, Monserrato
GSK Investigational Site, Roma
GSK Investigational Site, Girona
GSK Investigational Site, Sant Joan
GSK Investigational Site, Tarrasa, Barcelona
GSK Investigational Site, Gothenburg
GSK Investigational Site, Halmstad
GSK Investigational Site, Härnösand
GSK Investigational Site, Karlskrona
GSK Investigational Site, Karlstad
GSK Investigational Site, Kristianstad
GSK Investigational Site, Motala
GSK Investigational Site, Stockholm
GSK Investigational Site, Umeå
GSK Investigational Site, Vaxjo
GSK Investigational Site, Bath
GSK Investigational Site, Blackburn
GSK Investigational Site, Bristol
GSK Investigational Site, Hull
GSK Investigational Site, London
GSK Investigational Site, Newcastle upon Tyne
Lead Sponsor
Collaborators (1)
Juvenile Diabetes Research Foundation
OTHER
GlaxoSmithKline
INDUSTRY